Reviewed,
UniProtKB/Swiss-Prot P04859 (PHOSP_SENDH)
Last modified
November 24, 2009.
Version 65.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Phosphoprotein Short name=Protein P | ||
| Gene names |
| ||
| Organism | Sendai virus (strain Harris) (SeV) | ||
| Taxonomic identifier | 11196 [NCBI] | ||
| Taxonomic lineage | Viruses › ssRNA negative-strand viruses › Mononegavirales › Paramyxoviridae › Paramyxovirinae › Respirovirus | ||
| Virus host | Mus musculus (Mouse) [TaxID: 10090] Rattus norvegicus (Rat) [TaxID: 10116] Cavia cutleri (Guinea pig) [TaxID: 10144] Cricetidae sp. (Hamster) [TaxID: 36483] |
Protein attributes
| Sequence length | 568 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Essential component of the RNA polymerase transcription and replication complex. Binds the viral ribonucleocapsid and positions the L polymerase on the template. Acts as a chaperone for newly synthesized free N protein, so-called N0. Stabilizes the L protein upon binding it. |
| Subunit structure | Homotetramer. Binds to the L protein, N0 and to the C-terminal domain of N in ribonucleocapsid. Ref.3 Ref.4 Ref.5 |
| Subcellular location | |
| Domain | The L protein binding domain is necessary for viral RNA synthesis, whereas the N0 binding domain is not. Two separate regions are required for binding to the nucleocapsid. |
| Post-translational modification | Phosphorylated by PKC/PRKCZ, and other unknown kinases. Phosphorylation is necessary for viral transcription and replication. The N-terminus contains the majority of phosphorylated sites. Ser-249 is the major site of phosphorylation, but is not necessary for most functions. Ref.6 Ref.8 Ref.9 Ref.11 |
| Miscellaneous | The P/V/C gene has two overlapping open reading frames. One encodes the P/V/W proteins and the other the C/Y proteins. |
| Sequence similarities | Belongs to the respirovirus P protein family. |
| RNA editing | Edited at position 318. |
Ontologies
| Keywords | |
|---|---|
| Biological process | RNA replication |
| Cellular component | Host cytoplasm |
| Coding sequence diversity | RNA editing |
| Domain | Coiled coil |
| Molecular function | Chaperone |
| PTM | Phosphoprotein |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | transcription, RNA-dependent Inferred from electronic annotation. Source: UniProtKB-KW viral genome replicationInferred from electronic annotation. Source: InterPro |
| Cellular component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-KW host cell cytoplasmInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | RNA binding Inferred from electronic annotation. Source: InterPro RNA-directed RNA polymerase activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 568 | 568 | Phosphoprotein | PRO_0000142714 | ||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||
| Region | 33 – 41 | 9 | N(0) binding | |||||||||||||||||||||||
| Region | 345 – 412 | 68 | Bipartite nucleocapsid binding domain 1 | |||||||||||||||||||||||
| Region | 413 – 445 | 33 | L protein binding | |||||||||||||||||||||||
| Region | 479 – 568 | 90 | Bipartite nucleocapsid binding domain 2 | |||||||||||||||||||||||
| Coiled coil | 364 – 429 | 66 | ||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||
| Modified residue | 68 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
| Modified residue | 125 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
| Modified residue | 192 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
| Modified residue | 249 | 1 | Phosphoserine; by host Ref.6 Ref.9 | |||||||||||||||||||||||
| Modified residue | 257 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
| Modified residue | 260 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
| Modified residue | 447 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
| Modified residue | 449 | 1 | Phosphoserine; by host Ref.11 | |||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||
| Natural variant | 311 | 1 | S → T | |||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||
| Mutagenesis | 68 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 125 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 192 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 249 | 1 | S → A: No effect. Ref.9 | |||||||||||||||||||||||
| Mutagenesis | 249 | 1 | S → D: No effect. Ref.9 | |||||||||||||||||||||||
| Mutagenesis | 250 | 1 | P → A: Prevents S-249 phosphorylation. No effect on P protein functions. Ref.9 | |||||||||||||||||||||||
| Mutagenesis | 257 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 260 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 408 – 409 | 2 | KR → AA: 80% loss of in vitro transcription. | |||||||||||||||||||||||
| Mutagenesis | 412 – 416 | 5 | EYQKE → AYQAA: 60% loss of in vitro transcription. | |||||||||||||||||||||||
| Mutagenesis | 419 | 1 | S → A: No effect. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 421 | 1 | L → A: 80% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 425 | 1 | L → A: 80% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 426 | 1 | S → A: No effect. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 428 | 1 | L → A: 60% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 430 | 1 | I → A: No effect. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 433 – 437 | 5 | DRGGK → AAGGA: 80% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 436 | 1 | G → A: No effect. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 447 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 449 | 1 | S → A: Complete loss of phosphorylation. Ref.11 | |||||||||||||||||||||||
| Mutagenesis | 453 | 1 | K → A: 60% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 455 – 456 | 2 | KE → AA: 40% loss of in vitro transcription. | |||||||||||||||||||||||
| Mutagenesis | 460 – 465 | 6 | KATRFD → AATAFA: 80% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 469 – 473 | 5 | ETLED → ATLAA: 60% loss of in vitro transcription. Ref.10 | |||||||||||||||||||||||
| Mutagenesis | 482 – 485 | 4 | REDE → AAAA: Complete loss of in vitro replication and N(0) binding. | |||||||||||||||||||||||
| Mutagenesis | 487 – 489 | 3 | RDE → AAA: Complete loss of N(0) binding. | |||||||||||||||||||||||
| Mutagenesis | 497 – 499 | 3 | ERD → AAA: No effect. | |||||||||||||||||||||||
| Mutagenesis | 506 – 509 | 4 | NASR → AASA: Complete loss of transcription and replication. | |||||||||||||||||||||||
| Mutagenesis | 514 – 516 | 3 | KEK → AAA: 56% loss of transcription. | |||||||||||||||||||||||
| Mutagenesis | 524 – 526 | 3 | LVI → AAA: Complete loss of transcription, replication and N(0) binding. | |||||||||||||||||||||||
| Mutagenesis | 533 – 536 | 4 | RAEK → AAAA: 50% loss of transcription. Completely abolishes N(0) binding. | |||||||||||||||||||||||
| Mutagenesis | 549 – 553 | 5 | DQEVK → AQAVA: 50% loss of transcription. | |||||||||||||||||||||||
| Mutagenesis | 560 – 562 | 3 | EED → AAA: Complete loss of transcription, in vitro replication and N(0) binding. Ref.12 | |||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||
| Helix | 322 – 334 | 13 | ||||||||||||||||||||||||
| Beta strand | 337 – 339 | 3 | ||||||||||||||||||||||||
| Helix | 341 – 344 | 4 | ||||||||||||||||||||||||
| Helix | 350 – 359 | 10 | ||||||||||||||||||||||||
| Helix | 364 – 424 | 61 | ||||||||||||||||||||||||
| Helix | 425 – 428 | 4 | ||||||||||||||||||||||||
| Helix | 519 – 526 | 8 | ||||||||||||||||||||||||
| Helix | 534 – 544 | 11 | ||||||||||||||||||||||||
| Helix | 550 – 566 | 17 | ||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Sendai virus contains overlapping genes expressed from a single mRNA." Giorgi C., Blumberg B.M., Kolakofsky D. Cell 35:829-836(1983) [PubMed: 6317203] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA]. |
| [2] | Kolakofsky D. Submitted (JAN-2005) to UniProtKB Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA]. |
| [3] | "Separate domains of Sendai virus P protein are required for binding to viral nucleocapsids." Ryan K.W., Portner A. Virology 174:515-521(1990) [PubMed: 2154886] [Abstract] Cited for: INTERACTION WITH THE NUCLEOCAPSID. |
| [4] | "An acidic activation-like domain of the Sendai virus P protein is required for RNA SYnthesis and encapsidation." Curran J., Pelet T., Kolakofsky D. Virology 202:875-884(1994) [PubMed: 8030249] [Abstract] Cited for: INTERACTION WITH L PROTEIN. |
| [5] | "An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication." Curran J., Marq J.-B., Kolakofsky D. J. Virol. 69:849-855(1995) [PubMed: 7815552] [Abstract] Cited for: INTERACTION WITH NUCLEOPROTEIN N(0). |
| [6] | "Sendai virus P protein is constitutively phosphorylated at serine249: high phosphorylation potential of the P protein." Byrappa S., Pan Y.-B., Gupta K.C. Virology 216:228-234(1996) [PubMed: 8614993] [Abstract] Cited for: PHOSPHORYLATION AT SER-249. |
| [7] | "The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis." Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. EMBO J. 16:578-587(1997) [PubMed: 9034340] [Abstract] Cited for: RNA EDITING. |
| [8] | "Phosphorylation of Sendai virus phosphoprotein by cellular protein kinase C zeta." Huntley C.C., De B.P., Banerjee A.K. J. Biol. Chem. 272:16578-16584(1997) [PubMed: 9195969] [Abstract] Cited for: PHOSPHORYLATION BY PKC ZETA. |
| [9] | "Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis." Hu C.-J., Kato A., Bowman M.C., Kiyotani K., Yoshida T., Moyer S.A., Nagai Y., Gupta K.C. Virology 263:195-208(1999) [PubMed: 10544094] [Abstract] Cited for: PHOSPHORYLATION AT SER-249, MUTAGENESIS OF SER-249 AND PRO-250. |
| [10] | "Dissection of individual functions of the Sendai virus phosphoprotein in transcription." Bowman M.C., Smallwood S., Moyer S.A. J. Virol. 73:6474-6483(1999) [PubMed: 10400742] [Abstract] Cited for: MUTAGENESIS OF 408-LYS-ARG-409; 412-GLU--GLU-416; SER-419; LEU-421; LEU-425; SER-426; LEU-428; ILE-430; 433-ASP--LYS-437; GLY-436; LYS-453; 455-LYS-GLU-456; 460-LYS--ASP-465 AND 469-GLU--ASP-473. |
| [11] | "Functional significance of alternate phosphorylation in Sendai virus P protein." Hu C.-J., Gupta K.C. Virology 268:517-532(2000) [PubMed: 10704359] [Abstract] Cited for: PHOSPHORYLATION AT SER-68; SER-125; SER-192; SER-257; SER-260; SER-447 AND SER-449, MUTAGENESIS OF SER-68; SER-125; SER-192; SER-257; SER-260; SER-447 AND SER-449. |
| [12] | "The C-terminal 88 amino acids of the Sendai virus P protein have multiple functions separable by mutation." Tuckis J., Smallwood S., Feller J.A., Moyer S.A. J. Virol. 76:68-77(2002) [PubMed: 11739672] [Abstract] Cited for: MUTAGENESIS OF 482-ARG--GLU-485; 487-ARG--GLU-489; 497-GLU--ASP-499; 506-ASN-ARG-509; 514-LYS--LYS-516; 524-LEU--ILE-526; 533-ARG--LYS-536; 549-ASP--LYS-533 AND 560-GLU--ASP-562. |
| [13] | "Tetrameric coiled coil domain of Sendai virus phosphoprotein." Tarbouriech N., Curran J., Ruigrok R.W.H., Burmeister W.P. Nat. Struct. Biol. 7:777-781(2000) [PubMed: 10966649] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 320-433. |
| [14] | "Structure and dynamics of the nucleocapsid-binding domain of the Sendai virus phosphoprotein in solution." Blanchard L., Tarbouriech N., Blackledge M., Timmins P., Burmeister W.P., Ruigrok R.W.H., Marion D. Virology 319:201-211(2004) [PubMed: 14980481] [Abstract] Cited for: STRUCTURE BY NMR OF 516-568. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIR | RRNZHS. A28985. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR016075. RNA_pol_Pprot-P_XD_paramyxovir. IPR002693. RNA_pol_PProtein_C_Sendai-typ. [Graphical view] | ||||||||||||||||||
| Pfam | PF01806. Paramyxo_P. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Entry information
| Entry name | PHOSP_SENDH | ||||||||
| Accession | Primary (citable) accession number: P04859 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | Virus (Virus annotation project) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


